반려동물 귀감염증 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 동물 종별, 투여 방법별, 질환 유형별, 판매 채널별, 지역별, 경쟁(2021-2031년)
Companion Animal Ear Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Mode of Administration, By Disease Type, By Sales Channel, By Region & Competition, 2021-2031F
상품코드:1953406
리서치사:TechSci Research
발행일:2026년 01월
페이지 정보:영문 181 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 반려동물 귀감염증 치료 시장은 2025년 7억 4,184만 달러에서 2031년까지 11억 4,744만 달러로 확대하며, CAGR 7.54%를 기록할 것으로 예측되고 있습니다.
본 시장은 반려동물의 외이염 및 중이염 치료에 특화된 항생제, 항진균제, 코르티코스테로이드 등의 의약품 제제로 구성되어 있습니다. 성장의 주요 요인은 이차적으로 귀 감염을 유발하는 경우가 많은 아토피 피부염과 음식물 알레르기 발생률 증가입니다. 또한 반려동물 사육 가구의 지속적인 증가와 반려동물의 인간화 추세는 동물용 치료제 수요를 크게 증가시키고 있습니다. 미국 반려동물 제품 협회의 데이터에 따르면 2024년 미국 반려동물 산업 총 지출은 1,520억 달러에 달할 것으로 예상되며, 반려동물의 전문 건강관리에 대한 보호자들의 투자 의지가 높아지고 있음을 보여줍니다.
시장 개요
예측 기간
2027-2031년
시장 규모 : 2025년
7억 4,184만 달러
시장 규모 : 2031년
11억 4,744만 달러
CAGR : 2026-2031년
7.54%
가장 빠르게 성장하는 부문
E-Commerce
최대 시장
북미
이러한 성장 전망에도 불구하고 항생제 오남용과 그에 따른 항균제 내성 증가로 인해 시장은 큰 장벽에 직면해 있습니다. 규제 당국은 이 문제를 해결하기 위해 항생제를 많이 사용하는 귀 치료제의 처방에 대한 보다 엄격한 지침의 시행을 강화하고 있습니다. 이러한 규제 압력은 치료 프로토콜을 복잡하게 만들고 특정 1차 치료제에 대한 접근을 제한할 수 있으며, 이로 인해 시장의 광범위한 확장을 방해할 수 있습니다.
시장 성장 촉진요인
기저 알레르기성 및 피부 질환으로 인해 악화되는 외이염의 유병률 증가가 시장 성장의 주요 촉진요인으로 작용하고 있습니다. 개에서 가장 흔한 외이도 질환인 이 질환은 효과적인 항생제 및 코르티코스테로이드 치료에 대한 지속적인 수요를 창출하고 있습니다. 이러한 광범위한 임상적 실태는 보험 데이터에 의해 지원되며, Nationwide의 2025년 3월 기준 반려동물의 일반적 의료 상태 분석에 따르면 귀 감염은 반려견의 수의사 진료 이유 중 세 번째로 많은 원인으로 나타났습니다. 그 결과, 제약사들은 이러한 만성질환에 대한 치료법 채택이 빠르게 진행되고 있음을 확인했습니다. 예를 들어 Zoetis Inc.는 2025년 11월, 감염성 질환의 전조증상을 치료하는 피부과 제품군이 주요 견인차 역할을 하면서 국제적인 혁신적인 반려동물 제품 매출이 전년 대비 8% 증가했다고 보고했습니다.
동시에 반려동물 보험의 보급 확대는 동물 의료의 경제적 구조를 변화시켜 반복적이고 장기적인 치료를 보다 저렴하게 할 수 있도록 하고 있습니다. 만성이염의 재발성은 기존에는 경제적 부담과 치료 순응도 저하로 이어졌으나, 보험 가입률 증가로 이 장벽이 완화되었습니다. 수의사는 당장의 경제적 부담 없이 고가의 고가 치료제를 처방할 수 있게 되었습니다. 이러한 추세는 업계 성장에 의해 지원되고 있으며, 북미 반려동물보험협회(NAPHIA)는 2025년 6월, 2024년 미국 반려동물 보험 총 보험료가 47억 달러로 사상 최고치를 기록했다고 보고했습니다. 이러한 경제적 안전망이 확대되면서 더 많은 진단 사례가 필요한 약물 치료를 받을 수 있게 되어 장기적인 시장 매출이 유지되고 있습니다.
시장이 해결해야 할 과제
항생제 오남용과 이에 따른 항균제 내성 증가는 전 세계 반려동물 귀 감염 치료제 시장을 저해하는 중대한 과제입니다. 병원균이 표준 약물에 대한 내성을 개발함에 따라 규제 당국은 엄격한 관리 지침을 시행하여 항생제를 많이 사용하는 귀용 제제의 처방을 제한하고 있습니다. 이러한 규제 개입으로 인해 수의사들은 보다 보수적인 치료 프로토콜을 채택할 수밖에 없으며, 1차 치료제를 투여하기 전에 광범위한 진단적 근거를 요구하는 경우가 많아졌습니다. 이러한 장벽은 임상 과정을 연장시킬 뿐만 아니라 의약품 제제의 즉각적인 상업적 유통을 제한하고 기존 제품의 거래량을 직접적으로 감소시키고 있습니다.
이러한 규제의 영향은 제품 유통을 관리하는 수의학 전문가들의 업무 행태 변화로 인해 더욱 강화되고 있습니다. 2024년 영국 수의사 협회는 수의사의 85%가 항균제 사용에 대한 잠재적인 강제적 제한을 업계의 가장 중요한 관심사로 보고 있다고 보고했습니다. 이 통계는 향후 규제 위반에 대한 우려로 인해 사용 가능한 치료법의 사용이 감소하는 방어적인 처방 환경을 보여줍니다. 그 결과, 기존 항생제 기반 귀 감염 치료제에 대한 총 수요가 억제되어 귀 질환의 유병률이 증가하고 있음에도 불구하고 이 분야의 재정적 확장을 방해하고 있습니다.
시장 동향
항균제 무항생제 및 항균제 절약형 제제의 등장은 제조업체들이 증가하는 적정 사용 요청에 대응하면서 치료 환경을 변화시키고 있습니다. 수의학 전문가들은 외이염 치료, 특히 염증이나 효모균이 원인인 경우, 기존의 삼중 병용요법에 의존하는 대신 코르티코스테로이드 단독제제나 새로운 비항균제로의 전환을 추진하고 있습니다. 이러한 전략적 전환을 통해 수의사들은 심각한 세균성 질환에 중요한 항생제를 보존하면서 일상적인 감염을 효과적으로 관리할 수 있게 되었으며, 이러한 첨단 피부과 솔루션을 우선시하는 회사의 상업적 성장을 주도하고 있습니다. 버박의 2025년 1월 보도자료에 따르면 반려동물 부문의 매출은 10.7% 증가했으며, 이 실적은 이러한 전문 치료 옵션을 포함한 피부과 포트폴리오의 견고한 모멘텀에 기인하는 것으로 보고되었습니다.
동시에 AI 기반 자동 세포진단 및 진단 툴의 도입은 귀 감염 진단의 속도와 정확성에 혁명을 일으키고 있습니다. 동물병원에서는 인공지능을 활용하여 세균, 효모 등 귀 병원균을 즉시 확인할 수 있는 Point of Care 분석기 도입이 확대되고 있으며, 외부 검사기관 의뢰에 따른 지연을 효과적으로 해소하고 있습니다. 이러한 기술 통합은 임상 워크플로우의 효율성을 높이고, 초진시 즉각적인 근거에 기반한 치료 결정을 내릴 수 있게 합니다. 이러한 기술 시장 침투 속도는 분명합니다. IDEXX Laboratories의 2025년 11월 결산 보고서에서 1,750대 이상의 inVue Dx 분석기 도입을 강조하며, 수의학 현장의 자동화 진단 솔루션에 대한 수요가 가속화되고 있음을 보여주고 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 반려동물 귀감염증 치료 시장 전망
제6장 북미의 반려동물 귀감염증 치료 시장 전망
제7장 유럽의 반려동물 귀감염증 치료 시장 전망
제8장 아시아태평양의 반려동물 귀감염증 치료 시장 전망
제9장 중동 및 아프리카의 반려동물 귀감염증 치료 시장 전망
제10장 남미의 반려동물 귀감염증 치료 시장 전망
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 반려동물 귀감염증 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
제15장 경쟁 구도
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Companion Animal Ear Infection Treatment Market is projected to expand from USD 741.84 Million in 2025 to USD 1147.44 Million by 2031, reflecting a CAGR of 7.54%. This market consists of pharmaceutical formulations such as antibiotics, antifungals, and corticosteroids, which are specifically engineered to treat otitis externa and media in pets. Growth is primarily driven by the increasing incidence of atopic dermatitis and food allergies, which often lead to secondary ear infections. Additionally, the continued growth of the pet owner population and the trend toward pet humanization significantly increase the demand for veterinary therapeutics. Data from the American Pet Products Association indicates that total U.S. pet industry spending hit $152 billion in 2024, highlighting owners' growing willingness to fund specialized healthcare for their animals.
Market Overview
Forecast Period
2027-2031
Market Size 2025
USD 741.84 Million
Market Size 2031
USD 1147.44 Million
CAGR 2026-2031
7.54%
Fastest Growing Segment
E-commerce
Largest Market
North America
Despite these favorable growth prospects, the market faces a major obstacle due to antibiotic misuse and the resulting rise in antimicrobial resistance. Regulatory agencies are increasingly enforcing stricter guidelines regarding the prescription of antibiotic-heavy ear treatments to combat this issue. Such regulatory pressure complicates treatment protocols and potentially restricts access to certain first-line therapeutic options, thereby limiting broader market expansion.
Market Driver
The rising prevalence of otitis externa, frequently worsened by underlying allergic and dermatological issues, serves as a primary driver for market growth. As the most common ear canal disease in dogs, this condition generates a consistent, high-volume demand for effective antibiotic and corticosteroid treatments. This widespread clinical presence is confirmed by insurance data; Nationwide's March 2025 analysis of common pet medical conditions ranked ear infections as the third most frequent cause for veterinary visits among dogs. Consequently, pharmaceutical companies are seeing strong adoption of therapies for these chronic issues. For example, Zoetis Inc. reported in November 2025 that sales of its international innovative companion animal products, driven largely by dermatology portfolios addressing infection precursors, rose by 8% year-over-year.
Concurrently, the increasing penetration of pet health insurance is transforming the economic dynamics of veterinary care, making repeated and long-term treatments more affordable for owners. While the recurring nature of chronic ear infections historically caused financial strain and poor compliance, rising insurance adoption alleviates this barrier, allowing veterinarians to prescribe advanced, higher-cost therapeutics without immediate financial hesitation. This trend is supported by sector growth; the North American Pet Health Insurance Association (NAPHIA) reported in June 2025 that total U.S. pet insurance premiums reached a record $4.7 billion in 2024. This expanding financial safety net ensures that more diagnosed cases receive necessary pharmaceutical intervention, thereby sustaining long-term market revenue.
Market Challenge
The misuse of antibiotics and the subsequent increase in antimicrobial resistance represent a critical challenge hindering the Global Companion Animal Ear Infection Treatment Market. As pathogens develop resistance to standard drug classes, regulatory bodies are implementing strict stewardship guidelines that limit the prescription of antibiotic-heavy otic preparations. This regulatory intervention compels veterinarians to use more conservative treatment protocols, often requiring extensive diagnostic justification before administering first-line therapeutics. These barriers not only extend the clinical process but also restrict the immediate commercial distribution of pharmaceutical formulations, directly reducing transaction volumes for established products.
The impact of these restrictions is further intensified by changes in the operational behavior of veterinary professionals who control product dissemination. In 2024, the British Veterinary Association reported that 85 percent of veterinarians viewed potential enforced restrictions on antimicrobial use as a top industry concern. This statistic reveals a defensive prescribing environment where the fear of future regulatory non-compliance results in reduced utilization of available treatments. Consequently, the aggregate demand for conventional antibiotic ear infection medications is suppressed, hampering the sector's financial expansion despite the rising prevalence of otic conditions.
Market Trends
The rise of antibiotic-free and antimicrobial-sparing formulations is reshaping the therapeutic landscape as manufacturers respond to increasing stewardship demands. Instead of relying on traditional triple-combination therapies, veterinary professionals are shifting toward corticosteroid-only preparations and novel non-antibiotic agents to treat otitis externa, particularly in cases driven by inflammation or yeast. This strategic pivot allows veterinarians to reserve critical antibiotics for severe bacterial cases while effectively managing routine infections, driving substantial commercial growth for companies prioritizing these advanced dermatological solutions. Virbac's January 2025 press release reported a 10.7% revenue increase in its companion animal division, a performance explicitly attributed to the robust momentum of its dermatology portfolio containing these specialized therapeutic options.
Simultaneously, the adoption of AI-driven automated cytology and diagnostic tools is revolutionizing the speed and accuracy of ear infection diagnoses. Veterinary clinics are increasingly integrating point-of-care analyzers that utilize artificial intelligence to instantly identify otic pathogens such as bacteria and yeast, effectively eliminating the delays associated with external reference laboratories. This technological integration enhances clinical workflow efficiency and facilitates immediate, evidence-based treatment decisions during the initial patient visit. The rapid market uptake of these technologies is evident; IDEXX Laboratories' November 2025 earnings report highlighted the placement of over 1,750 inVue Dx analyzers, demonstrating the accelerating demand for automated diagnostic solutions in veterinary practice.
Key Market Players
Zoetis Inc.
Elanco Animal Health Inc.
Dechra Pharmaceuticals Plc
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
VETOQUINOL S.A.
Virbac S.A.
Ceva Animal Health, LLC
Vedco Inc.
OurPetsLife Limited
Report Scope
In this report, the Global Companion Animal Ear Infection Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Companion Animal Ear Infection Treatment Market, By Product
Antibacterial
Anti-fungal
Corticosteroids
Others
Companion Animal Ear Infection Treatment Market, By Animal Type
Dogs
Cats
Others
Companion Animal Ear Infection Treatment Market, By Mode of Administration
Topical
Oral
Otic
Companion Animal Ear Infection Treatment Market, By Disease Type
Otitis Externa
Otitis Media
Otitis Interna
Companion Animal Ear Infection Treatment Market, By Sales Channel
Hospital/ Clinic Pharmacy
Retail Pharmacies
E-commerce
Companion Animal Ear Infection Treatment Market, By Region
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Ear Infection Treatment Market.
Available Customizations:
Global Companion Animal Ear Infection Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Companion Animal Ear Infection Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Antibacterial, Anti-fungal, Corticosteroids, Others)
5.2.2. By Animal Type (Dogs, Cats, Others)
5.2.3. By Mode of Administration (Topical, Oral, Otic)
5.2.4. By Disease Type (Otitis Externa, Otitis Media, Otitis Interna)
5.2.5. By Sales Channel (Hospital/ Clinic Pharmacy, Retail Pharmacies, E-commerce)
5.2.6. By Region
5.2.7. By Company (2025)
5.3. Market Map
6. North America Companion Animal Ear Infection Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Mode of Administration
6.2.4. By Disease Type
6.2.5. By Sales Channel
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Companion Animal Ear Infection Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Animal Type
6.3.1.2.3. By Mode of Administration
6.3.1.2.4. By Disease Type
6.3.1.2.5. By Sales Channel
6.3.2. Canada Companion Animal Ear Infection Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Animal Type
6.3.2.2.3. By Mode of Administration
6.3.2.2.4. By Disease Type
6.3.2.2.5. By Sales Channel
6.3.3. Mexico Companion Animal Ear Infection Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Animal Type
6.3.3.2.3. By Mode of Administration
6.3.3.2.4. By Disease Type
6.3.3.2.5. By Sales Channel
7. Europe Companion Animal Ear Infection Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Mode of Administration
7.2.4. By Disease Type
7.2.5. By Sales Channel
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Companion Animal Ear Infection Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Animal Type
7.3.1.2.3. By Mode of Administration
7.3.1.2.4. By Disease Type
7.3.1.2.5. By Sales Channel
7.3.2. France Companion Animal Ear Infection Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Animal Type
7.3.2.2.3. By Mode of Administration
7.3.2.2.4. By Disease Type
7.3.2.2.5. By Sales Channel
7.3.3. United Kingdom Companion Animal Ear Infection Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Animal Type
7.3.3.2.3. By Mode of Administration
7.3.3.2.4. By Disease Type
7.3.3.2.5. By Sales Channel
7.3.4. Italy Companion Animal Ear Infection Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Animal Type
7.3.4.2.3. By Mode of Administration
7.3.4.2.4. By Disease Type
7.3.4.2.5. By Sales Channel
7.3.5. Spain Companion Animal Ear Infection Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Animal Type
7.3.5.2.3. By Mode of Administration
7.3.5.2.4. By Disease Type
7.3.5.2.5. By Sales Channel
8. Asia Pacific Companion Animal Ear Infection Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Animal Type
8.2.3. By Mode of Administration
8.2.4. By Disease Type
8.2.5. By Sales Channel
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Companion Animal Ear Infection Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Animal Type
8.3.1.2.3. By Mode of Administration
8.3.1.2.4. By Disease Type
8.3.1.2.5. By Sales Channel
8.3.2. India Companion Animal Ear Infection Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Animal Type
8.3.2.2.3. By Mode of Administration
8.3.2.2.4. By Disease Type
8.3.2.2.5. By Sales Channel
8.3.3. Japan Companion Animal Ear Infection Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Animal Type
8.3.3.2.3. By Mode of Administration
8.3.3.2.4. By Disease Type
8.3.3.2.5. By Sales Channel
8.3.4. South Korea Companion Animal Ear Infection Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Animal Type
8.3.4.2.3. By Mode of Administration
8.3.4.2.4. By Disease Type
8.3.4.2.5. By Sales Channel
8.3.5. Australia Companion Animal Ear Infection Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Animal Type
8.3.5.2.3. By Mode of Administration
8.3.5.2.4. By Disease Type
8.3.5.2.5. By Sales Channel
9. Middle East & Africa Companion Animal Ear Infection Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Animal Type
9.2.3. By Mode of Administration
9.2.4. By Disease Type
9.2.5. By Sales Channel
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Companion Animal Ear Infection Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Animal Type
9.3.1.2.3. By Mode of Administration
9.3.1.2.4. By Disease Type
9.3.1.2.5. By Sales Channel
9.3.2. UAE Companion Animal Ear Infection Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Animal Type
9.3.2.2.3. By Mode of Administration
9.3.2.2.4. By Disease Type
9.3.2.2.5. By Sales Channel
9.3.3. South Africa Companion Animal Ear Infection Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Animal Type
9.3.3.2.3. By Mode of Administration
9.3.3.2.4. By Disease Type
9.3.3.2.5. By Sales Channel
10. South America Companion Animal Ear Infection Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Animal Type
10.2.3. By Mode of Administration
10.2.4. By Disease Type
10.2.5. By Sales Channel
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Companion Animal Ear Infection Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Animal Type
10.3.1.2.3. By Mode of Administration
10.3.1.2.4. By Disease Type
10.3.1.2.5. By Sales Channel
10.3.2. Colombia Companion Animal Ear Infection Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Animal Type
10.3.2.2.3. By Mode of Administration
10.3.2.2.4. By Disease Type
10.3.2.2.5. By Sales Channel
10.3.3. Argentina Companion Animal Ear Infection Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Animal Type
10.3.3.2.3. By Mode of Administration
10.3.3.2.4. By Disease Type
10.3.3.2.5. By Sales Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Companion Animal Ear Infection Treatment Market: SWOT Analysis
